Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Haloperidol decanoate - Generic Drug Details

« Back to Dashboard

What are the generic sources for haloperidol decanoate and what is the scope of haloperidol decanoate freedom to operate?

Haloperidol decanoate
is the generic ingredient in two branded drugs marketed by Janssen Pharms, West-ward Pharms Int, Mylan Labs Ltd, Sandoz Inc, Hospira, Fresenius Kabi Usa, and Teva Pharms Usa, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol decanoate. Seven suppliers are listed for this compound.

Summary for Generic Name: haloperidol decanoate

Drug Master File Entries: see list20
Suppliers / Packagers: see list7
Bulk Api Vendors: see list18
Clinical Trials: see list45
Patent Applications: see list232
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:haloperidol decanoate at DailyMed

Pharmacology for Ingredient: haloperidol decanoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
haloperidol decanoate
INJECTABLE;INJECTION075176-002Feb 9, 2000DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
haloperidol decanoate
INJECTABLE;INJECTION075305-001Sep 28, 1998AORXNoNo► Subscribe► Subscribe
Janssen Pharms
haloperidol decanoate
INJECTABLE;INJECTION018701-001Jan 14, 1986AORXYesYes► Subscribe► Subscribe
Sandoz Inc
haloperidol decanoate
INJECTABLE;INJECTION076463-002Jun 24, 2005DISCNNoNo► Subscribe► Subscribe
Mylan Labs Ltd
haloperidol decanoate
INJECTABLE;INJECTION075440-001Feb 28, 2000AORXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus